Saltar al contenido
MilliporeSigma

Protective effect of gastrin-releasing peptide receptor antagonist in carrageenan-induced pleural inflammation in rats.

Inflammation research : official journal of the European Histamine Research Society ... [et al.] (2010-04-07)
Fabricia Petronilho, Bruna de Souza, Francieli Vuolo, César A F Benetton, Emilio L Streck, Rafael Roesler, Gilberto Schwartsmann, Felipe Dal-Pizzol
RESUMEN

We report the effects of the gastrin-releasing peptide (GRP) receptor antagonist RC-3095 in an acute inflammation model induced by carrageenan. Male Wistar rats received saline or saline containing 2% lambda-carrageenan into the pleural cavity, with some also receiving RC-3095 3 mg/kg subcutaneously, immediately after surgery. Four hours later, the rats were killed and pleural exudate was obtained for evaluation of total cell count, lactate dehydrogenase activity, total protein, cytokines analysis and nitrite/nitrate concentrations; myeloperoxidase (MPO) activity and oxidative stress were evaluated in the lung. RC-3095 exhibited pronounced anti-inflammatory actions by inhibition of leukocyte influx and blockade of MPO, nitrite/nitrate and cytokine levels. Moreover, the results showed that RC-3095 elicits action against oxidative damage in lipids and proteins, as well as increasing cell viability. The present findings suggest that GRP plays a role in acute inflammation that can be related with the reduction of oxidative damage and that it could be effective in therapeutic applications.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
RC-3095, ≥95% (HPLC), lyophilized powder